FDA Inspection
Sanofi-Aventis Deutschland GmbHSanofi-Aventis Deutschland GmbH – FDA Inspection, Jan 16, 2025
Record Details
This FDA Inspection record concerns Sanofi-Aventis Deutschland GmbH, with an inspection on January 16, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 348390ff-d4e4-4542-a78b-5ee0f5c4d748
Inspection Facts
- Inspection number
- 1262770
- FDA center
- Human Drugs
Other FDA inspections of Sanofi-Aventis Deutschland GmbH
11| Date | Classification | Office | Project area |
|---|---|---|---|
| March 25, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 14, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 3, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 10, 2015 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| June 26, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Sanofi-Aventis Deutschland GmbH
- FDA Inspection 1215824 - 2022-03-25
- FDA Inspection 1094836 - 2019-05-14
- FDA Inspection 1006001 - 2017-03-03
- FDA Inspection 952968 - 2015-12-10
- FDA Inspection 933399 - 2015-06-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.